Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06675357 · ClinicalTrials.gov registry record · Phase 2

Using FAPI PET/MRI to Evaluate Prostate Cancer

A Phase 2 study of Prostate Cancer Metastatic Disease and Prostate Cancers, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT06675357 is a Phase 2 study of Prostate Cancer Metastatic Disease and Prostate Cancers that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants, below the 49-participant average among 5 other Prostate Cancer Metastatic Disease trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06675357, a Phase 2 study of Prostate Cancer Metastatic Disease and Prostate Cancers, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumor tissue. The main question it aims to answer is how this information can be used to better diagnose and track prostate cancer. Participants will undergo two PET/MRI scans during two research visits, each of which may last up to 2.5 hours.

Conditions Studied

Prostate Cancer Metastatic Disease Prostate Cancers

Interventions

  • PROCEDURE Magnetic Resonance Imaging
  • RADIATION FAPI
  • PROCEDURE Positron Emission Tomography (PET)

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-02-27
Est. Completion 2027-01
Phase Phase 2

Sponsor

University of Wisconsin, Madison

1,039 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06675357

The ClinicalTrials.gov registry entry for NCT06675357 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 49-participant average among 5 other Prostate Cancer Metastatic Disease trials with a reported enrollment target (39% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer Metastatic Disease appearing as the primary indexed condition, and to 3 interventions - of which Magnetic Resonance Imaging is the first listed.

NCT06675357 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06675357 about?

NCT06675357 is a clinical study titled "Using FAPI PET/MRI to Evaluate Prostate Cancer". The goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumor tissue. The main question it aims to answer is how this information can be used to better diagnose and track prostate cancer. Participants...

What is the current status of trial NCT06675357?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2026-02-27. Estimated completion is 2027-01.

What conditions does trial NCT06675357 study?

This clinical trial studies the following conditions: Prostate Cancer Metastatic Disease, Prostate Cancers.

What interventions are being tested in trial NCT06675357?

The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), FAPI (RADIATION), Positron Emission Tomography (PET) (PROCEDURE).

Who is sponsoring clinical trial NCT06675357?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06675357 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer Metastatic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer Metastatic Disease

All registered trials for this condition

Prostate Cancers

All registered trials for this condition

Wisconsin

All trials with a study site in Wisconsin

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.